Remarkably, three exosome-associated proteins have been suggested as candidate biomarkers for PD: clusterin, apolipoprotein A1, and complement C1r subcomponent, the levels of which were found elevated in PD patients compared to healthy controls [169]. Here, CLU is linked to Parkinson disease.